FY2025 · ended Dec 31, 2025 · Revenue $2.53B, -1.5% YoY · Filed Feb 26, 2026
Teladoc Health, Inc. (TDOC) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.5 billion and a net loss of $200.3 million. Free cash flow was $285.5 million. As of Sep 30, 2026 it held $849.9 million in cash and investments and $37.6 million in total debt.
Revenue (TTM)
$2.47B
-2.4% vs year-ago TTM
Net income (TTM)
$-154.82M
+30.8% vs year-ago TTM
Operating cash flow (TTM)
$268.38M
-8.3% vs year-ago TTM
Free cash flow (TTM)
$261.96M
-6.5% vs year-ago TTM
EPS (TTM)
$-0.86
+32.7% vs year-ago TTM
Dividend per share
None
Shares outstanding
178.40M
+2.7% vs prior year
Net cash
$812.35M
as of Sep 30, 2026
Operating margin
-6.6%
FY 2026
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- TDOC (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1477449
- Former names
- Teladoc, Inc. (until Aug 1, 2018)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Starling Oncology, Inc. STLN
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.6B | $2.6B | $2.4B | $2.0B |
| Operating income | -$263.0M | -$1.0B | -$248.6M | -$13.7B | -$265.6M |
| Net income | -$200.3M | -$1.0B | -$220.4M | -$13.7B | -$428.8M |
| Diluted EPS | -$1.14 | -$5.87 | -$1.34 | -$84.60 | -$2.73 |
| Operating cash flow | $294.4M | $293.7M | $350.0M | $189.3M | $194.0M |
| Free cash flow | $285.5M | $282.9M | $338.6M | $172.8M | $185.5M |
| Total assets | $2.9B | $3.5B | $4.4B | $4.3B | $17.7B |
| Total liabilities | $1.5B | $2.0B | — | — | — |
| Stockholders' equity | $1.4B | $1.5B | $2.3B | $2.3B | $16.0B |
| Cash and investments | $781.1M | $1.3B | $1.1B | $918.2M | $896.0M |
| Total debt | $45.2M | $42.5M | $53.6M | $51.6M | $54.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 31, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
All 1000 Teladoc Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.